These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Induction of virus-neutralizing antibodies by bacteria expressing the C3 poliovirus epitope in the periplasm. The route of immunization influences the isotypic distribution and the biologic activity of the antipoliovirus antibodies. LeClerc C, Martineau P, Van der Werf S, Deriaud E, Duplay P, Hofnung M. J Immunol; 1990 Apr 15; 144(8):3174-82. PubMed ID: 2157762 [Abstract] [Full Text] [Related]
3. Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins. Leclerc C, Lo-Man R, Charbit A, Martineau P, Clément JM, Hofnung M. Int Rev Immunol; 1994 Apr 15; 11(2):123-32. PubMed ID: 7519229 [Abstract] [Full Text] [Related]
5. Expression and immune response to foreign epitopes in bacteria. Perspectives for live vaccine development. Charbit A, Newton SM, Klebba PE, Clément JM, Fayolle C, Lo-Man R, Leclerc C, Hofnung M. Behring Inst Mitt; 1997 Feb 15; (98):135-42. PubMed ID: 9382734 [Abstract] [Full Text] [Related]
8. Immunodominance of a recombinant T-cell epitope depends on its molecular environment. Leclerc C, Martineau P, Charbit A, Lo-Man R, Dériaud E, Hofnung M. Mol Immunol; 1993 Dec 15; 30(17):1561-72. PubMed ID: 8247026 [Abstract] [Full Text] [Related]
10. Immunogenicity of viral B-cell epitopes inserted into two surface loops of the Escherichia coli K12 LamB protein and expressed in an attenuated aroA strain of Salmonella typhimurium. Wang J, Michel V, Leclerc C, Hofnung M, Charbit A. Vaccine; 1999 Jan 15; 17(1):1-12. PubMed ID: 10078601 [Abstract] [Full Text] [Related]
12. Molecular and cellular parameters controlling the immunogenicity of foreign B- or T-cell epitopes expressed by recombinant vectors. Leclerc C, Lo-Man R, Fayolle C, Charbit A, Clément JM, Martineau P, O'Callaghan D, Hofnung M. Dev Biol Stand; 1994 Jan 15; 82():193-9. PubMed ID: 7525391 [Abstract] [Full Text] [Related]
13. Presentation of two epitopes of the preS2 region of hepatitis B virus on live recombinant bacteria. Charbit A, Sobczak E, Michel ML, Molla A, Tiollais P, Hofnung M. J Immunol; 1987 Sep 01; 139(5):1658-64. PubMed ID: 2442253 [Abstract] [Full Text] [Related]
16. Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein. Coëffier E, Clément JM, Cussac V, Khodaei-Boorane N, Jehanno M, Rojas M, Dridi A, Latour M, El Habib R, Barré-Sinoussi F, Hofnung M, Leclerc C. Vaccine; 2000 Nov 22; 19(7-8):684-93. PubMed ID: 11115689 [Abstract] [Full Text] [Related]
17. Expression of a poliovirus neutralization epitope at the surface of recombinant bacteria: first immunization results. Charbit A, Van der Werf S, Mimic V, Boulain JC, Girard M, Hofnung M. Ann Inst Pasteur Microbiol; 1988 Nov 22; 139(1):45-58. PubMed ID: 2454645 [Abstract] [Full Text] [Related]
18. Permissive sites and topology of an outer membrane protein with a reporter epitope. Charbit A, Ronco J, Michel V, Werts C, Hofnung M. J Bacteriol; 1991 Jan 22; 173(1):262-75. PubMed ID: 1702781 [Abstract] [Full Text] [Related]